SCHEMBL7147050

SCHEMBL7147050

O=C(O)[C@@H]1C[C@@H](S)CN1C(=O)OCC1c2ccccc2-c2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
FABP5 Q01469 3/20 0.45
FABP7 O15540 2/20 0.45
KMT2A Q03164 2/20 0.43
EPHX2 P34913 1/20 0.39
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
MDM4 O15151 1/20 0.36
TP53 P04637 1/20 0.36
AGTR2 P50052 1/20 0.35
CASP3 P42574 2/20 0.35
ECE1 P42892 1/20 0.35
DPP8 Q6V1X1 1/20 0.35
DPP9 Q86TI2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1000853 0.86 FABP5 (0.46) FABP5FABP7KMT2AEPHX2
SCHEMBL7604791 0.86 FABP5 (0.46) FABP5FABP7KMT2AEPHX2CA1
SCHEMBL4612189 0.86 FABP5 (0.46) FABP5FABP7KMT2AEPHX2
SCHEMBL1336708 0.86 FABP5 (0.46) FABP5FABP7KMT2AEPHX2
SCHEMBL16838567 0.86 FABP5 (0.46) FABP5FABP7KMT2AEPHX2CA1
SCHEMBL1334889 0.86 FABP5 (0.46) FABP5FABP7KMT2AEPHX2
SCHEMBL1000852 0.86 FABP5 (0.46) FABP5FABP7KMT2AEPHX2
SCHEMBL1335555 0.86 FABP5 (0.46) FABP5FABP7KMT2AEPHX2
SCHEMBL16153163 0.86 FABP5 (0.46) FABP5FABP7KMT2AEPHX2CA1
SCHEMBL7606819 0.86 FABP5 (0.46) FABP5FABP7KMT2AEPHX2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6541638-B2 (2S,4S)-1-(4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carbonyl)-piperidine-4-carboxylic acid ethyl ester for example; zinc protease inhibitors; for treating diseases associated with vasoconstriction HOFFMAN-LA ROCHE INC. 2003-04-01 US disclosed